Tue, Jul 22, 2014, 8:47 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Albany Molecular Research Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • stk_hnter stk_hnter Aug 6, 2008 7:09 PM Flag

    This is a Perfect Example of Why You Should Ignore Downgrades or Upgrades

    group1759 wrote: "This is a Perfect Example of Why You Should Ignore Downgrades or Upgrades . . . "

    With all due respect, how did you reach this conclusion?

    The track record for AMRI hasn't been good. The stock has been a laggard since Dec. 2000. In recent prior quarters, management failed to meet market expectations and, in some cases, missed their own guidance targets.

    I won't rain on anyone's parade today because it would appear to be sour grapes. But it's easy to snear at the pros who might have recently downgraded an individual stock, such as AMRI, and it ended up having a good quarter. The pros look at the numbers, track records and make their calls. It's business. It's not personal. Yes, sooner or later, most situations relate to The Godfather.

    Everyone's a Monday Morning QB. When will they ever learn? That's their job - to learn. They have people (bosses, clients or investors) looking over their shoulders every day. Day-to-day, year-to-year, Bull and Bear markets, they need to be correct with at least 51% of their bets.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Analysts are paid by brokerage houses who have their agendas. Not very unbiased!

      My favorite holding gets screwed over by Goldman Sachs because Goldman Sachs took public a competitor. So guess how the Goldman analysts evaluate my holding.

 
AMRI
20.39+0.52(+2.62%)Jul 22 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Puma Biotechnology, Inc.
NYSETue, Jul 22, 2014 4:01 PM EDT
Microsoft Corporation
NasdaqGSTue, Jul 22, 2014 4:00 PM EDT